GRIT Biotechnology

Beijing, China · Founded 2019 · Privately Held (backing)

Developer of immunotherapy intended to cure solid tumors. GRIT Biotechnology is based in Beijing, China and was founded in 2019. Its last reported valuation was $291 million in Oct 2025. It has raised $124 million.

Last reported valuation
$291.3M
Oct 2026
Priced at
—
Total raised
$124.2M
Last round
—

Who backs GRIT Biotechnology?

22 investors
InvestorType
GL VenturesVenture capital
CICC CapitalPE / buyout
B Capital GroupVenture capital
Green Pine Capital PartnersVenture capital
Qianhai FoFFund of funds
Shun Xi FundPE / buyout
Zhongguancun Development Venture Capital FundOther
CNPC Kunlun CapitalVenture capital
Loyal Valley CapitalVenture capital
Hengqin Financial InvestmentOther
+ 12 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

GRIT Biotechnology investors

22 investors are on record for GRIT Biotechnology, including GL Ventures, CICC Capital, B Capital Group and Green Pine Capital Partners. By type, the record holds 5 venture capital firms and 2 private equity firms.

Free account
More of GRIT Biotechnology with a free account
  • ·The complete investor list: 22 names
  • ·Watch GRIT Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 22 firms already write checks for companies like GRIT Biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View